Effect of Remimazolam and Propofol on Postoperative Delirium

Recruiting now · Not applicable

Conditions studied: Hip Fractures, Knee Osteoarthritis, Femur Fracture

In brief

Remimazolam is an ultra-short acting benzodiazepine agonist which is used widely for general anesthesia and sedation. Remimazolam has several advantages. Remimazolam is rapidly metabolized by tissue esterase that it does not accumulate even after infusion for long periods of time. The presence of reversal agents (flumazenil) is also advantageous. Also, hemodynamic stability compared to propofol gives clinicians preference to use for geriatric anesthesia. However, the study on the effect of remimazolam compared to propofol on postoperative delirium have not been carried out. The purpose of the study is to compare the incidence of postoperative delirium and recovery profile in elderly patients undergoing orthopedic surgery using either remimazolam or propofol.

Key facts

Study ID
NCT05514405
Run by
Inje University
People needed
82
Starts
2022-08-01
Expected to finish
2026-09-30
Last updated by the study team
2026-03-27

Who can join

Age: 65 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.